Literature DB >> 11229183

Early haemodialysis in acute tubular necrosis.

M L Pursnani1, D K Hazra, B Singh, D N Pandey.   

Abstract

The study was conducted in 35 cases of acute tubular necrosis of varied aetiology. Cases were divided in 2 groups, Group A--17 cases treated conservatively and Group B--18 cases managed by early haemodialysis. Criteria for early haemodialysis were blood urea < 120 mg% and serum creatinine < 7 mg%. Before starting therapy both the groups had comparable biochemical and renal parameters (p > 0.05). Overall mortality was lower in Group B as compared to Group A (22.2% Vs 29.4). Complication events such as uraemic encephalopathy, pulmonary oedema, haematemesis and malena, thrombophlebitis and vomiting were significantly lower in Group B (p < 0.05). Hospital stay was also significantly lower (p < 0.05) in Group B (18 +/- 2.5 days Vs 28 +/- 3 days), this can reduce the cost of treatment also.

Entities:  

Mesh:

Year:  1997        PMID: 11229183

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  10 in total

Review 1.  Timing of initiation of renal replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized-controlled trials.

Authors:  Yongxing Xu; Jianjun Gao; Xinming Zheng; Bo Zhong; Yu Na; Jiamei Wei
Journal:  Clin Exp Nephrol       Date:  2016-08-02       Impact factor: 2.801

2.  Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery.

Authors:  Chih-Chung Shiao; Vin-Cent Wu; Wen-Yi Li; Yu-Feng Lin; Fu-Chang Hu; Guang-Huar Young; Chin-Chi Kuo; Tze-Wah Kao; Down-Ming Huang; Yung-Ming Chen; Pi-Ru Tsai; Shuei-Liong Lin; Nai-Kuan Chou; Tzu-Hsin Lin; Yu-Chang Yeh; Chih-Hsien Wang; Anne Chou; Wen-Je Ko; Kwan-Dun Wu
Journal:  Crit Care       Date:  2009-10-30       Impact factor: 9.097

3.  Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury.

Authors:  Marlies Ostermann; René Ws Chang
Journal:  Crit Care       Date:  2009-11-04       Impact factor: 9.097

Review 4.  Timing of renal replacement therapy for patients with acute kidney injury: A systematic review and meta-analysis.

Authors:  Mark Andonovic; Richard Shemilt; Malcolm Sim; Jamie P Traynor; Martin Shaw; Patrick B Mark; Kathryn A Puxty
Journal:  J Intensive Care Soc       Date:  2020-02-06

5.  Timing of renal replacement therapy initiation for acute kidney injury.

Authors:  Alicia Isabel I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

6.  Early initiation of renal replacement treatment in patients with acute kidney injury: A systematic review and meta-analysis.

Authors:  Hongwei Wang; Liwei Li; Qinjun Chu; Yong Wang; Zhisong Li; Wei Zhang; Lanlan Li; Long He; Yanqiu Ai
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials.

Authors:  Girish Chandra Bhatt; Rashmi Ranjan Das
Journal:  BMC Nephrol       Date:  2017-02-28       Impact factor: 2.388

8.  An isolated elevation in blood urea level is not 'uraemia' and not an indication for renal replacement therapy in the ICU.

Authors:  Jack Mackenzie; Bobby Chacko
Journal:  Crit Care       Date:  2017-11-13       Impact factor: 9.097

9.  Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis.

Authors:  Jia-Jin Chen; Cheng-Chia Lee; George Kuo; Pei-Chun Fan; Chan-Yu Lin; Su-Wei Chang; Ya-Chung Tian; Yung-Chang Chen; Chih-Hsiang Chang
Journal:  Ann Intensive Care       Date:  2020-03-03       Impact factor: 6.925

10.  Timing of initiation of renal replacement therapy in acute kidney injury: an updated meta-analysis of randomized controlled trials.

Authors:  Ling Zhang; Dezheng Chen; Xin Tang; Peiyun Li; Yong Zhang; Ye Tao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.